{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T11:43:35Z","timestamp":1791373415163,"version":"4.3.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Neurodegenerative diseases (NDs) such as Parkinson\u2019s disease (PD), Alzheimer\u2019s disease (AD), amyotrophic lateral sclerosis (ALS), Huntington\u2019s disease (HD) are set apart by progressive neuronal loss and concomitant functional decline. Traditional therapies are equipped with only symptomatic relief, devoid of neurorestorative properties. Stem-cell-based therapies have the potential to revolutionize neurological care by replenishing lost cells, mitigating inflammation, and fostering a neuroprotective environment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>This narrative review aims to appraise the treatment potential of various stem cell types in managing NDs, highlighting their functional pathways, delivery methods, and current experimental validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive literature search was carried out based on data retrieved from PubMed, The Cochrane Library, and ClinicalTrials.gov. Thirty-one studies that fulfill PICO criteria and only English-language publications are incorporated in this review. No part of the study design, data collection, analysis, or interpretation was conducted using artificial intelligence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Stem cells, including embryonic stem cells, mesenchymal stem cells (MSCs), induced pluripotent stem cells, and neural stem cells, possess distinctive regenerative properties. MSC-derived exosomes can traverse the blood\u2013brain barrier and improve nerve cell longevity. Administration routes such as intravenous, intranasal, and direct brain transplantation are being studied. Neurodegenerative conditions such as PD, AD, HD, and ALS have been widely studied for therapeutic benefits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Regardless of their potential, stem cell therapies raise health risks, including neoplastic growth and immunological incompatibility, alongside bioethical issues. Developments in genetic modification, nanotechnology, and preconditioning strategies are being analyzed to optimize outcomes. Long-term research, harmonization of protocols, and extended patient follow-up are essential for the safe and effective development of medical applications.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000004490","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T14:01:31Z","timestamp":1765375291000},"page":"1441-1453","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["A narrative review on the therapeutic potential of stem cells in neurodegenerative diseases: advances, insights, and challenges"],"prefix":"10.1097","volume":"88","author":[{"given":"Tirath","family":"Patel","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Trinity Medical Sciences University School of Medicine, Saint Vincent and the Grenadines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathimathul","family":"Henna","sequence":"additional","affiliation":[{"name":"Dubai Medical College for Girls, Dubai, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman","family":"Sharif","sequence":"additional","affiliation":[{"name":"Akhtar Saeed Medical and Dental College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inaya","family":"Javed","sequence":"additional","affiliation":[{"name":"Akhtar Saeed Medical and Dental College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Mustafa","sequence":"additional","affiliation":[{"name":"Akhtar Saeed Medical and Dental College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannan","family":"Sharif","sequence":"additional","affiliation":[{"name":"Akhtar Saeed Medical and Dental College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Nasir","sequence":"additional","affiliation":[{"name":"Akhtar Saeed Medical and Dental College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirat","family":"Javaid","sequence":"additional","affiliation":[{"name":"Akhtar Saeed Medical and Dental College, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samman Fatima","family":"Usman","sequence":"additional","affiliation":[{"name":"Texas Institute for Graduate Medical Education and Research, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hanani","sequence":"additional","affiliation":[{"name":"Department of Neurology, Henry Ford Health, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhilesh","family":"Anand","sequence":"additional","affiliation":[{"name":"Department of Medical Education, University of Texas Rio Grande Valley, Edinburg, TX, United States of America"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"R1-20260810","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.3390\/cells10081992","article-title":"Stem cells: innovative therapeutic options for neurodegenerative diseases?","volume":"10","author":"Bonaventura","year":"2021","journal-title":"Cells"},{"key":"R2-20260810","first-page":"981\u201389","article-title":"Application of mesenchymal stem cells in the discovery of therapy for neurodegenerative diseases","volume":"26","author":"Trinh","year":"2024","journal-title":"Regen Ther"},{"key":"R3-20260810","doi-asserted-by":"crossref","first-page":"101547","DOI":"10.1016\/j.disamonth.2023.101547","article-title":"Newer modalities in the management of Alzheimer\u2019s dementia along with the role of aducanumab and lecanemab in the treatment of its refractory cases","volume":"69","author":"Marsool","year":"2023","journal-title":"Dis Mon"},{"key":"R4-20260810","doi-asserted-by":"crossref","DOI":"10.14336\/AD.2023.0904","article-title":"Mesenchymal stem cells-based cell-free therapy targeting neuroinflammation","author":"Xu","year":"2023","journal-title":"Aging Dis"},{"key":"R5-20260810","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.3390\/cells11213476","article-title":"Stem-cell-based therapy: the celestial weapon against neurological disorders","volume":"11","author":"Zayed","year":"2022","journal-title":"Cells"},{"key":"R6-20260810","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.3390\/ijms22169047","article-title":"Combination of drugs and cell transplantation: more beneficial stem cell-based regenerative therapies targeting neurological disorders","volume":"22","author":"Nishimura","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R7-20260810","doi-asserted-by":"crossref","first-page":"165506","DOI":"10.1016\/j.bbadis.2019.06.020","article-title":"Neural regeneration therapies for Alzheimer\u2019s and Parkinson\u2019s disease-related disorders","volume":"1866","author":"Reddy","year":"2020","journal-title":"Biochim Biophys Acta BBA - Mol Basis Dis"},{"key":"R8-20260810","doi-asserted-by":"crossref","first-page":"179","DOI":"10.31083\/j.jin.2020.01.1142","article-title":"Neural stem cell secretome and its role in the treatment of neurodegenerative disorders","volume":"19","author":"Zhang","year":"2020","journal-title":"J Integr Neurosci"},{"key":"R9-20260810","first-page":"100082","article-title":"Transparency in the reporting of Artificial Intelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R10-20260810","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3390\/ijms22042153","article-title":"Regenerative stem cell therapy for neurodegenerative diseases: an overview","volume":"22","author":"Sivandzade","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R11-20260810","doi-asserted-by":"crossref","first-page":"611\u201326","DOI":"10.2147\/IJN.S395010","article-title":"Nanotherapeutic and stem cell therapeutic strategies in neurodegenerative diseases: a promising therapeutic approach","volume":"18","author":"Wei","year":"2023","journal-title":"Int J Nanomedicine"},{"key":"R12-20260810","doi-asserted-by":"crossref","first-page":"6367\u201381","DOI":"10.1097\/JS9.0000000000001609","article-title":"Recent advances in stem cell therapy: efficacy, ethics, safety concerns, and future directions focusing on neurodegenerative disorders \u2013 a review","volume":"110","author":"Khandia","year":"2024","journal-title":"Int J Surg"},{"key":"R13-20260810","doi-asserted-by":"crossref","first-page":"383\u201393","DOI":"10.1093\/stcltm\/szac006","article-title":"Neural stem\/progenitor cell transplantation in parkinson\u2019s rodent animals: a meta-analysis and systematic review","volume":"11","author":"Zheng","year":"2022","journal-title":"Stem Cells Transl Med"},{"key":"R14-20260810","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.3390\/ijms21093103","article-title":"Neural stem cell transplantation for neurodegenerative diseases","volume":"21","author":"De Gioia","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R15-20260810","first-page":"147","article-title":"Stem cell transplantation therapy and neurological disorders: current status and future perspectives","volume":"11","author":"Rahman","year":"2022","journal-title":"Biology (Basel)"},{"key":"R16-20260810","first-page":"157\u201370","article-title":"Prospects of induced pluripotent stem cells in treating advancing Alzheimer\u2019s disease: a review","volume":"40","author":"Park","year":"2025","journal-title":"Histol Histopathol"},{"key":"R17-20260810","doi-asserted-by":"crossref","first-page":"8060","DOI":"10.3390\/ijms21218060","article-title":"Stem cell-based therapies for parkinson disease","volume":"21","author":"Liu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R18-20260810","doi-asserted-by":"crossref","first-page":"1347987","DOI":"10.3389\/fnagi.2024.1347987","article-title":"The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets","volume":"16","author":"Adamu","year":"2024","journal-title":"Front Aging Neurosci"},{"key":"R19-20260810","doi-asserted-by":"crossref","first-page":"1\u20138","DOI":"10.1155\/2020\/8889061","article-title":"Stem cell therapy for neurodegenerative diseases: how do stem cells bypass the blood-brain barrier and home to the brain?","volume":"2020","author":"Chia","year":"2020","journal-title":"Stem Cells Int"},{"key":"R20-20260810","doi-asserted-by":"crossref","first-page":"110673","DOI":"10.1016\/j.brainresbull.2023.110673","article-title":"Advances in stem cell and other therapies for Huntington\u2019s disease: an update","volume":"199","author":"Conner","year":"2023","journal-title":"Brain Res Bull"},{"key":"R21-20260810","doi-asserted-by":"crossref","first-page":"15\u201326","DOI":"10.1002\/ame2.12207","article-title":"Stem cell therapy for alzheimer\u2019s disease: an overview of experimental models and reality","volume":"5","author":"Qin","year":"2022","journal-title":"Anim Models Exp Med"},{"key":"R22-20260810","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13287-023-03264-0","article-title":"Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials","volume":"14","author":"Ghasemi","year":"2023","journal-title":"Stem Cell Res Ther"},{"key":"R23-20260810","doi-asserted-by":"crossref","DOI":"10.1590\/1980-5764-dn-2024-0147","article-title":"A systematic review of clinical efficacy and safety of cell-based therapies in Alzheimer\u2019s disease","volume":"18","author":"Feizi","year":"2024","journal-title":"Dement Neuropsychol"},{"key":"R24-20260810","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.3390\/ijms21155241","article-title":"Insights into the effects of mesenchymal stem cell-derived secretome in parkinson\u2019s disease","volume":"21","author":"d\u2019Angelo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R25-20260810","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/ijms22031433","article-title":"Mesenchymal stem cell-derived exosomes as new remedy for the treatment of neurocognitive disorders","volume":"22","author":"Harrell","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R26-20260810","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13287-025-04285-7","article-title":"Cell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases","volume":"16","author":"Deng","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"R27-20260810","doi-asserted-by":"crossref","first-page":"107833","DOI":"10.1016\/j.parkreldis.2025.107833","article-title":"Allogenic transplantation therapy of iPScell-derived dopamine progenitors for parkinson\u2019s disease -current status of the kyoto trial and future perspectives","volume":"135","author":"Takahashi","year":"2025","journal-title":"Parkinsonism Relat Disord"},{"key":"R28-20260810","article-title":"Stem cell extracellular vesicles: a new dawn for anti-inflammatory treatment of neurodegenerative diseases","author":"Yu","year":"2025","journal-title":"Front Aging Neurosci"},{"key":"R29-20260810","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/cells14010042","article-title":"Advances in stem cell therapy for huntington\u2019s disease: a comprehensive literature review","volume":"14","author":"Shah","year":"2025","journal-title":"Cells"},{"key":"R30-20260810","doi-asserted-by":"crossref","first-page":"e2294","DOI":"10.1212\/WNL.0000000000008620","article-title":"NurOwn, phase 2, randomized, clinical trial in patients with ALS: safety, clinical, and biomarker results","volume":"93","author":"Berry","year":"2019","journal-title":"Neurology"},{"key":"R31-20260810","doi-asserted-by":"crossref","first-page":"35\u201356","DOI":"10.1016\/j.biochi.2023.02.012","article-title":"Therapeutical growth in oligodendroglial fate induction via transdifferentiation of stem cells for neuroregenerative therapy","volume":"211","author":"Dwivedi","year":"2023","journal-title":"Biochimie"},{"key":"R32-20260810","doi-asserted-by":"crossref","first-page":"1569717","DOI":"10.3389\/fmmed.2025.1569717","article-title":"Neural stem cells in adult neurogenesis and their therapeutic applications in neurodegenerative disorders: a concise review","volume":"5","author":"Bayleyegn Derso","year":"2025","journal-title":"Front. Mol. Med"},{"key":"R33-20260810","first-page":"413\u201330","article-title":"Exploring the multiple therapeutic mechanisms and challenges of mesenchymal stem cell-derived exosomes in alzheimer\u2019s disease","volume":"18","author":"nan","year":"2024","journal-title":"Biosci Trends"},{"key":"R34-20260810","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3390\/biom10091320","article-title":"Promising opportunities for treating neurodegenerative diseases with mesenchymal stem cell-derived exosomes","volume":"10","author":"Guy","year":"2020","journal-title":"Biomolecules"},{"key":"R35-20260810","doi-asserted-by":"crossref","first-page":"214\u201330","DOI":"10.1002\/ibra.12095","article-title":"Research progress in clinical trials of stem cell therapy for stroke and neurodegenerative diseases","volume":"9","author":"Yan","year":"2023","journal-title":"Ibrain"},{"key":"R36-20260810","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.3233\/JAD-221298","article-title":"Hosney M. miRNAs and stem cells as promising diagnostic and therapeutic targets for alzheimer\u2019s disease","volume":"94","author":"Elzayat","year":"2023","journal-title":"J Alzheimers Dis JAD"},{"key":"R37-20260810","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3390\/biomedicines11082168","article-title":"Progress and prospects of gene editing in pluripotent stem cells","volume":"11","author":"Zhang","year":"2023","journal-title":"Biomedicines"},{"key":"R38-20260810","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s13287-024-04089-1","article-title":"Advances in genetically modified neural stem cell therapy for central nervous system injury and neurological diseases","volume":"15","author":"Tang","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"R39-20260810","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1002\/mco2.291","article-title":"Application of stem cells in regeneration medicine","volume":"4","author":"Jin","year":"2023","journal-title":"MedComm"},{"key":"R40-20260810","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3390\/ijms23031184","article-title":"Gut\u2013brain axis as a pathological and therapeutic target for neurodegenerative disorders","volume":"23","author":"Toledo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R41-20260810","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3390\/cells9071636","article-title":"Advances in tissue engineering and innovative fabrication techniques for 3-D-structures: translational applications in neurodegenerative diseases","volume":"9","author":"Rey","year":"2020","journal-title":"Cells"},{"key":"R42-20260810","doi-asserted-by":"crossref","first-page":"512\u201329","DOI":"10.1016\/j.stem.2023.03.017","article-title":"Advancing cell therapy for neurodegenerative diseases","volume":"30","author":"Temple","year":"2023","journal-title":"Cell Stem Cell"},{"key":"R45-20260810","doi-asserted-by":"crossref","DOI":"10.1186\/s13287-025-04334-1","article-title":"Stem cell therapy: a revolutionary cure or a pandora\u2019s box","volume":"16","author":"Marei","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"R46-20260810","first-page":"8547\u201365","article-title":"Mesenchymal stem cell-derived extracellular vesicles: emerging therapies for neurodegenerative diseases","volume":"20","author":"Chen","year":"2025","journal-title":"Int. J. Nanomed[Internet]"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000004490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:03:41Z","timestamp":1786359821000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000004490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000004490","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"2025-04-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}